JP Patent

JP5377968B2 — 癌治療のために単独で用いるまたは化学療法薬と併用するヒストンデアセチラーゼ（ｈｄａｃ）阻害剤

Assigned to トポターゲット ユーケー リミテッド · Expires 2013-12-25 · 12y expired

What this patent protects

Patent listed against Crenessity.

Drugs covered by this patent

Patent Metadata

Patent number
JP5377968B2
Jurisdiction
JP
Classification
—
Expires
2013-12-25
Drug substance claim
No
Drug product claim
No
Assignee
トポターゲット ユーケー リミテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.